AMH Test · Blood

If you want to know how many eggs your ovaries have left, there is one number that answers that question better than any other. AMH (anti-Mullerian hormone) gives you a snapshot of your ovarian reserve, the pool of eggs available to mature and potentially be fertilized. It is the single most accurate blood test for estimating that pool, and unlike most reproductive hormones, you can draw it on any day of your cycle.

What AMH cannot tell you is just as important. A low number does not mean you cannot get pregnant, and a normal number does not guarantee that you can. AMH measures egg quantity, not egg quality, and not your actual odds of conceiving in any given month. Understanding what it does and does not reveal is the key to using it wisely.

What AMH Actually Measures

AMH is a protein made by granulosa cells, the support cells that surround each developing egg inside its follicle. Production begins when a resting egg first wakes up and starts growing, peaks in the small follicles visible on ultrasound (up to about 8 mm), and shuts off as a follicle matures toward ovulation or dies off. The total AMH released into your blood reflects how many of these small growing follicles are active at any given time.

That growing follicle pool is in rough proportion to the much larger reservoir of resting eggs you were born with. As that reservoir shrinks with age, AMH falls. Levels typically rise through childhood, peak in the late teens to early twenties, then decline steadily until they become undetectable a few years before menopause. The rate of decline varies enormously between women of the same age, which is exactly why measuring it is useful.

Egg Quantity, Not Egg Quality

This distinction matters more than almost anything else in this article. AMH tells you roughly how many eggs remain. It does not tell you whether those eggs carry the right number of chromosomes or are capable of producing a healthy pregnancy. Egg quality is driven primarily by age. A 28 year old with a low AMH still has young, high-quality eggs, just fewer of them. A 42 year old with a high AMH has plenty of eggs, but a larger fraction may carry chromosome problems simply because of biological aging.

In a study of 750 women aged 30 to 44 without known infertility, those with biomarkers indicating diminished ovarian reserve had similar chances of conceiving naturally over six to twelve cycles as women with normal reserve markers. AMH predicted egg number, not the ability to get pregnant in any given month.

Where AMH Shines: IVF and Ovarian Stimulation

The clinical setting where AMH has the strongest evidence is assisted reproduction. When your ovaries are stimulated with fertility drugs to produce multiple eggs at once, AMH is the best predictor of how your ovaries will respond. Women with high AMH tend to produce many eggs and face a higher risk of ovarian hyperstimulation syndrome (OHSS), a potentially serious complication. Women with low AMH tend to produce fewer eggs and face a higher chance of cycle cancellation.

Meta-analyses consistently show AMH outperforms FSH (follicle-stimulating hormone), estradiol, and inhibin B (another follicle-produced hormone) for predicting ovarian response. It performs at least as well as antral follicle count (the ultrasound-based measure of small follicles), with the advantage that a blood test does not depend on the skill of the ultrasound operator or the quality of the equipment. Fertility clinics now routinely use AMH to individualize drug dosing, choosing lower doses for high responders and higher doses for low responders.

PCOS and Elevated AMH

Women with polycystic ovary syndrome (PCOS) typically have AMH levels two to four times higher than age-matched peers. This reflects the hallmark of PCOS: an unusually large number of small antral follicles that stall in early development rather than maturing toward ovulation. Recent international guidelines now accept AMH as a way to identify this polycystic ovarian pattern in adults, as an alternative to ultrasound.

In a trial of 333 women with PCOS treated with clomiphene and metformin, those with AMH above 8 ng/mL had significantly lower odds of ovulating in response to treatment. Very high AMH in PCOS is not a sign of superior fertility. It signals a more resistant form of anovulation, meaning the ovary fails to release a mature egg each month, that may require different treatment strategies.

Menopause Timing and Premature Ovarian Insufficiency

Because AMH tracks the shrinking follicle pool, it carries information about when menopause is approaching. In the SWAN study (Study of Women's Health Across the Nation), which followed 1,537 women, AMH predicted time to final menstrual period more accurately than FSH. Very low AMH (below roughly 0.1 ng/mL) in women over 45 was strongly associated with menopause arriving within one to three years. Above 2.0 ng/mL, menopause within five years was unlikely regardless of age.

For younger women, the prediction window is much wider, often spanning two to twelve years, which limits individual-level usefulness. Where AMH is most informative is in identifying women at risk for premature ovarian insufficiency (POI), the early loss of ovarian function before age 40. Very low AMH in a woman under 35, especially with a family history of early menopause, warrants further evaluation and fertility counseling.

Heart Disease and Type 2 Diabetes Risk

Emerging evidence links AMH to outcomes beyond reproduction. In the Doetinchem Cohort, which followed over 3,100 women for up to 20 years, each 1 ng/mL drop in AMH was associated with roughly 21% higher risk of cardiovascular disease and 26% higher risk of coronary heart disease, even after adjusting for standard risk factors like blood pressure, cholesterol, and smoking. Women whose AMH declined faster had about 46% to 56% higher cardiovascular risk.

In the same cohort, women in the highest third of age-specific AMH had about 38% lower risk of developing type 2 diabetes compared to those in the lowest third. These associations likely reflect the broader health implications of ovarian aging: earlier loss of ovarian function accelerates metabolic and vascular changes that drive disease. AMH here acts as a barometer of reproductive aging speed, not a direct cause.

Breast Cancer Association

A pooled analysis across ten prospective cohorts including 2,835 breast cancer cases and 3,122 matched controls found that premenopausal women in the highest quarter of AMH had about 60% higher odds of developing breast cancer compared to those in the lowest quarter. For hormone-receptor-positive tumors specifically, the association was even stronger, with roughly double the odds. This held after adjusting for standard breast cancer risk factors.

This does not mean high AMH causes breast cancer. Mendelian randomization studies, which use inherited genetic variants as stand-ins for AMH levels to test cause-and-effect, did not find a clear causal link. This suggests the association may reflect shared biology, such as longer lifetime estrogen exposure, rather than a direct AMH effect. For now, this finding is observational context, not a reason to try lowering your AMH.

Reference Ranges: Age Is Everything

There is no single "normal" AMH. The same level that would be perfectly healthy in a 38 year old could signal diminished reserve in a 25 year old, or suggest PCOS if accompanied by irregular cycles. AMH must always be interpreted relative to your age. Different assays also produce different numbers for the same blood sample, with variation of up to 40% between platforms. Always compare results from the same lab.

The following ranges are drawn from a study of 841 healthy women using a modern automated assay. They provide general orientation, not absolute targets. Your lab may use a different assay with slightly different values.

Compare your results within the same lab over time for the most meaningful trend. A single reading near a clinical cutpoint may reflect normal biological fluctuation rather than a true shift in your reserve.

When Results Can Be Misleading

AMH is more stable than most reproductive hormones, but several factors can push the number down without meaning your egg supply has actually shrunk.

• Hormonal contraception: Birth control pills, patches, and hormonal IUDs suppress follicle activity and can lower AMH by roughly 9% to 55%. This effect reverses after stopping, but if you test while on hormonal contraception, your result will underestimate your true reserve. Allow at least two to three months off before testing for an accurate reading.
• Smoking: Current smokers have AMH roughly 4 to 44% lower than nonsmokers. This appears reversible with cessation, and likely reflects a real but modest toxic effect on follicle health.
• Assay differences: AMH tests are not yet standardized internationally. Values from different labs or different assay platforms cannot be directly compared. If you are tracking over time, use the same lab and same assay.
• Vitamin D deficiency: AMH levels correlate positively with vitamin D status. In women with low vitamin D, AMH may read lower than it would at sufficient vitamin D levels, though the clinical significance of this effect is debated.

Tracking Your Trend

A single AMH result is a useful data point, but a trend over time tells you much more. The intra-individual coefficient of variation, a measure of how much the same person's result bounces around, is about 20%. That means a result of 2.0 ng/mL could naturally read anywhere from about 1.6 to 2.4 on repeat testing. Nearly 29% of women in one study crossed a clinical cutpoint on retesting, especially in the low range.

Get a baseline reading in your late twenties or early thirties. If you are making changes (stopping hormonal contraception, starting fertility treatment, or recovering from chemotherapy), retest in three to six months. After that, annual testing gives you a trajectory. A single low result should be confirmed with a repeat test before any major decision. If your level is declining faster than expected for your age, that pattern is the signal, not any one number.

What to Do With an Abnormal Result

If your AMH is low for your age, your first step is to rule out confounders. Were you on hormonal contraception? Is your vitamin D sufficient? Did you use the same lab as your last test? If the result holds on repeat testing, the next move depends on your situation.

• If you are trying to conceive: A reproductive endocrinologist can pair AMH with an antral follicle count (ultrasound), FSH, and estradiol to build a full picture of your reserve. Low AMH does not mean IVF is your only option, but it does mean time matters more.
• If you are not yet trying: Low AMH at a young age is a prompt to think about your reproductive timeline sooner rather than later. Egg freezing or embryo banking may be worth discussing.
• If your AMH is very high (above 4 to 5 ng/mL with irregular cycles): This pattern suggests PCOS. A workup including testosterone, LH, FSH, fasting insulin, and glucose will help clarify the diagnosis and guide treatment.
• If you have had cancer treatment: AMH tracks ovarian damage from chemotherapy and radiation. Undetectable AMH after treatment strongly suggests severe follicle depletion, but some recovery is possible depending on the regimen. An oncofertility specialist can help interpret the trajectory.